In a RCT of the effect of a new cholesterol medication, patients were randomly assigned to either the Drug group or the Placebo group.Both groups were followed, however, Some patients were not followed for a total of 10 years.Some suffered events (i.e., developed coronary artery disease during the course of follow-up) while others dropped out of the study.The following table displays the total number of person-years of follow-up in each group.Compute the incidence rate of coronary artery disease in patients receiving the new medication.

Group	Number with Coronary Artery Disease	Total Years of Follow-Up
Cholesterol Medication	43	1372
Placebo	110	1978